Sibylla Biotech logo

Sibylla Biotech

Developer of patent-based software designed to apply algorithms and drug design protocols. The company's software focuses on drug discovery protocols based on original reaction path sampling and data reduction algorithms to avoid folding and thus bring the protein to degradation.

1

Funding Rounds

$23.0m

Money raised

Overview

Developer of patent-based software designed to apply algorithms and drug design protocols. The company's software focuses on drug discovery protocols based on original reaction path sampling and data reduction algorithms to avoid folding and thus bring the protein to degradation.

Funding series

Funding Series Analysis

The company Sibylla Biotech has raised a total of $23m in funding over 1 rounds.

Key Insights:

  • Sibylla Biotech September 2022 Series A Funding Round: $23m
Sibylla Biotech logo
Sibylla Biotech September 2022 Series A Funding Round $23m

Industries

Sibylla Biotech is active in the following industries: